Advertisement
Research Article

Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPs

  • Nancy J Sullivan equal contributor,

    equal contributor Contributed equally to this work with: Nancy J Sullivan, Thomas W Geisbert

    Affiliation: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Thomas W Geisbert equal contributor,

    equal contributor Contributed equally to this work with: Nancy J Sullivan, Thomas W Geisbert

    Affiliation: United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America

    X
  • Joan B Geisbert,

    Affiliation: United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America

    X
  • Devon J Shedlock,

    Affiliation: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Ling Xu,

    Affiliation: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Laurie Lamoreaux,

    Affiliation: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Jerome H. H. V Custers,

    Affiliation: Crucell Holland B.V., Leiden, Netherlands

    X
  • Paul M Popernack,

    Affiliation: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Zhi-Yong Yang,

    Affiliation: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Maria G Pau,

    Affiliation: Crucell Holland B.V., Leiden, Netherlands

    X
  • Mario Roederer,

    Affiliation: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Richard A Koup,

    Affiliation: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Jaap Goudsmit,

    Affiliation: Crucell Holland B.V., Leiden, Netherlands

    X
  • Peter B Jahrling,

    Affiliation: Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Gary J Nabel mail

    To whom correspondence should be addressed. E-mail: gnabel@nih.gov

    Affiliation: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Published: May 16, 2006
  • DOI: 10.1371/journal.pmed.0030177

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.